超声术前评估新诊断乳腺癌肿瘤大小的准确性:是否受背景实质回声类型影响?
研究纳入2014年1月至2015年12月140例新诊断浸润性乳腺癌女性,两位放射科医生回顾性共识判读超声图像背景实质回声类型,记录静态图像最大肿瘤直径,以与病理大小相差±5 mm内为测量一致。背景实质回声均匀者测量准确性87.0%,不均匀者63.5%(P=.001);小肿瘤(<2 cm)、导管原位癌阴性、HER2阴性及三阴性型也测量更准确,独立相关因素为背景实质回声不均匀、肿瘤较大及HER2富集型(P<.05)。结论认为背景实质回声类型影响乳腺超声肿瘤大小评估准确性。
要点
- 背景实质回声不均匀者超声测量肿瘤大小准确性63.5%,低于均匀者的87.0%(P=.001)。
- 肿瘤≥2 cm及HER2富集型是超声测量不准确的独立相关因素(P<.05)。
- 以与病理大小相差±5 mm内为测量一致,总体测量准确性为76.4%(104/140)。
核心结论
- 背景实质回声类型影响乳腺超声肿瘤大小评估的准确性,肿瘤较大(≥2 cm)及HER2富集型浸润性乳腺癌的超声测量准确性显著低于其他类型。
研究设计与样本
- 回顾性研究,纳入2014年1月至2015年12月140例新诊断浸润性乳腺癌女性,两位放射科医生共识判读超声图像背景实质回声类型,记录静态图像最大肿瘤直径,以组织病理学大小为参考标准。
关键影像表现/征象
- 140例中背景实质回声均匀者77例(55.0%),不均匀者63例(45.0%)。
- 肿瘤平均大小1.9 cm(范围0.5-4.9 cm)。
诊断标准与关键数值
- 肿瘤大小测量与病理结果相差在±5 mm以内视为一致。
- 总体测量准确性76.4%(104/140);背景实质回声均匀者87.0%,不均匀者63.5%(P=.001)。
- 肿瘤<2 cm者测量更准确(P=.018);导管原位癌阴性者更准确(P=.031);HER2阴性者更准确(P=.053);三阴性型更准确(P=.016)。
- 与测量不准确独立相关的因素为背景实质回声不均匀、肿瘤较大及HER2富集型(P<.05)。
临床应用与阅片要点
- 阅片测量肿瘤大小时应关注背景实质回声类型,不均匀背景可能降低测量准确性。
- 对≥2 cm肿瘤及HER2富集型乳腺癌,超声测量大小需谨慎解读。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the impact of the background parenchymal echotexture on the accuracy of tumor size estimation using breast ultrasound (US).
METHODS: A total of 140 women with newly diagnosed invasive breast cancer from January 2014 to December 2015 were enrolled in this study. Two radiologists retrospectively reviewed US images in consensus for background parenchymal echotexture interpretation. The maximum tumor diameter from static images was recorded. Tumor size measurements were considered as having agreement with histologic results if they were within ±5 mm compared to the pathologic size. The relationship between the accuracy of tumor size measurement by the background parenchymal echotexture and clinicopathologic characteristics was evaluated.
RESULTS: Of these 140 patients, 77 (55.0%) showed a homogeneous background parenchymal echotexture, whereas 63 (45.0%) showed a heterogeneous echotexture. The mean tumor size was 1.9 cm (range, 0.5-4.9 cm). The overall accuracy of tumor size measurement was 76.4% (104 of 140). Tumors of women with a homogeneous background parenchymal echotexture were more accurately measured than those of women with a heterogeneous echotexture (87.0% versus 63.5%; P = .001). Tumors with a small size (<2 cm; P = .018) and ductal carcinoma in situ-negative (P = .031), human epidermal growth factor receptor 2 (HER2)-negative (P = .053), and triple-negative (P = .016) types were also more accurately measured. The independent factors associated with inaccurate tumor size measurement were a heterogeneous background parenchymal echotexture, a large tumor size, and the HER2-enriched type (P < .05).
CONCLUSIONS: The background parenchymal echotexture affected the accuracy of tumor size estimation using breast US. Invasive breast cancers with large (≥2 cm) tumors and the HER2-enriched type showed significantly lower breast US accuracy compared to others.
引用
- Ko KH, Son EJ, Kim IW, et al. Accuracy of Ultrasound for Preoperative Assessment of Tumor Size in Patients With Newly Diagnosed Breast Cancer: Is It Affected by the Background Parenchymal Echotexture? J Ultrasound Med. 2018. PMID: 29665100. doi:10.1002/jum.14622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。